Featured Image
Why is it important?
In the recent past, pharmaceutical expenditure has been steadily increasing, but the productivity of the sector - measured as the number of New Molecular Entities (NMEs) has been decreasing. Understanding the effects of regulation on innovation is a primary objective to design the best policy instruments
Read the Original
This page is a summary of: Drug Prices and Incentives to Innovation by the Pharmaceutical Industry, November 2014, Springer Science + Business Media,
DOI: 10.1007/978-3-319-12169-7_21.
You can read the full text:
Contributors
The following have contributed to this page
